VSports最新版本 - Emerging cancer therapeutic opportunities by inhibiting mitotic kinases
- PMID: 18644252
- DOI: "VSports注册入口" 10.1016/j.coph.2008.06.013
Emerging cancer therapeutic opportunities by inhibiting mitotic kinases
Abstract
Among cellular kinases, several cell cycle protein kinases play critical roles in mitotic entry and chromosome segregation. Inhibition of these proteins frequently results in dramatic mitotic arrest and subsequent apoptosis. Most drug discovery efforts have been directed against members of the cyclin-dependent kinase (CDK), Aurora and Polo-like kinase families VSports手机版. Inhibition of these proteins with small molecules has emerged as a powerful research tool and their clinical use is currently being tested in phase I and phase II trials for cancer therapy. New unexplored kinases or new protein domains distinct to the kinase pocket are now being evaluated for the next generation of mitotic drugs. The therapeutic value of inhibiting these kinases will improve with the availability of new specific and potent inhibitors, but it will also rely on a better knowledge of the physiological requirement for these proteins in normal and tumor cell cycles. .
Publication types (VSports在线直播)
- "V体育官网" Actions
MeSH terms
- "VSports在线直播" Actions
- Actions (VSports最新版本)
- V体育官网入口 - Actions
- "VSports注册入口" Actions
- "V体育ios版" Actions
- Actions (V体育官网)
- "VSports在线直播" Actions
Substances
- Actions (VSports最新版本)
Grants and funding
LinkOut - more resources
"VSports" Full Text Sources
Other Literature Sources
